Gulfan, Arbania G.

HRN: 28-01-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
CEFUROXIME 500MG (TAB)
10/29/2025
11/04/2025
PO
500 Mg
BID
UTI Following Delivery
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: